Santa Clara-based healthcare technology company Semler Scientific, Inc. SMLR has expanded its Bitcoin BTC/USD holdings with the purchase of an additional 303 BTC for $29.3 million between Nov. 25 and Dec. 4.
This acquisition brings the company’s total Bitcoin holdings to 1,873 BTC, valued at approximately $180.4 million at current market prices.
The average purchase price for these holdings stands at $78,553 per Bitcoin.
The latest Bitcoin purchase was funded through proceeds from Semler's at-the-market (ATM) equity offering.
On Nov. 25, the company increased the offering to $100 million, generating $79.8 million in gross proceeds by early December.
Chairman Eric Semler emphasized the company's focus on its Bitcoin treasury strategy, highlighting a BTC Yield of 78.7% since July 2024.
This proprietary metric tracks the percentage change in Bitcoin holdings relative to Semler's assumed diluted shares outstanding, serving as an internal performance indicator.
Semler's adoption of Bitcoin as a treasury asset is part of a broader diversification strategy aimed at aligning with evolving market trends.
The company views Bitcoin as a potential store of value and hedge against macroeconomic uncertainty.
However, it cautioned that the BTC Yield metric should not be interpreted as a traditional financial performance measure, as it is designed primarily for internal assessment.
The announcement coincides with Bitcoin's recent rally above $100,000, underscoring the growing role of digital assets in corporate treasury management.
Semler's strategy reflects a broader shift among corporations recognizing the value of integrating cryptocurrencies into their financial frameworks.
As part of its ongoing initiatives, the company has also applied for options trading approval for its stock, signaling an effort to provide additional mechanisms for investor participation.
Read Next:
Image: Shutterstock
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.